Sunday, 7 June 2026
CereVasc's $85M funding secured, Pets in One Health surveillance, Minocycline's modest stroke benefits
- 01
CereVasc secures $85M for minimally invasive brain treatment
CereVasc has raised $85 million in a Series C funding round led by Piper Sandler Merchant Banking, with participation from Johnson & Johnson and Medtronic. The funding will support a pivotal trial for its eShunt device, designed to treat normal pressure hydrocephalus through a minimally invasive endovascular approach. This trial, which began in 2024, aims to compare the eShunt to traditional ventriculoperitoneal shunt procedures. The study focuses on assessing gait impairment and adverse events over a six-month period, with potential implications for outpatient treatment.
via MedTech Dive
- 02
Integrating Pets into One Health Surveillance Proposed
A correspondence in The Lancet advocates for the integration of pets into One Health surveillance frameworks. The authors highlight the increasing risks to human health from climate change, biodiversity loss, and pollution, which necessitate a holistic approach. They suggest that companion animals, particularly dogs, cats, and birds, can serve as early-warning sentinels for emerging infectious diseases and exposure to toxic chemicals. This integration could enhance disease prevention and monitoring efforts.
via The Lancet
- 03
EMPHASIS trial shows modest benefits of minocycline for stroke
The EMPHASIS trial indicates a modest increase in 90-day functional outcomes for patients with acute ischaemic stroke receiving a 4.5-day course of minocycline. While the study revisits the concept of neuroprotection in the context of reperfusion therapy, its design features raise concerns about the generalisability of the findings. These limitations may affect how the results influence treatment protocols moving forward.
via The Lancet · also covered by The Lancet
- 04
Ebola outbreak in DR Congo and Uganda escalates
The Ebola virus disease outbreak in the Democratic Republic of Congo and Uganda has reached a critical stage, with 116 suspected cases, 330 confirmed cases, and 49 reported deaths. WHO Director-General Tedros Adhanom Ghebreyesus acknowledged that the outbreak is outpacing the current response efforts. The situation is exacerbated by reduced funding from traditional donors and weakened multilateral support, placing additional strain on already fragile health systems.
via The Lancet
- 05
South Korea Achieves Notable Hypertension Control
South Korea has successfully controlled hypertension through dedicated policy efforts over the past 15 years. This achievement positions the country among the few globally to manage this condition effectively. The strategies employed may offer insights for improving cardiovascular health outcomes elsewhere.
via The Lancet
- 06
Donald Warne discusses Indigenous health inequities
Donald Warne, a Professor in International Health and Co-Director of the Johns Hopkins Center for Indigenous Health, reflects on his experiences in primary care medicine, noting that many issues he encountered were preventable. Warne, a member of the Oglala Lakota tribe, graduated from Stanford University in 1995 and later earned a master's in public health from Harvard University in 2002, focusing on health policy. His insights contribute to ongoing discussions about addressing health inequities in Indigenous populations.
via The Lancet
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.